Protalix BioTherapeutics (PLX)

Add to Watchlists
Create an Alert
4.15 -0.03  -0.72% AMEX Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
PLX Price Chart
View All Performance Charts

PLX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Protalix BioTherapeutics is down 25.89% over the last year vs S&P 500 Total Return up 23.54%, Biogen Idec up 42.37%, and Jazz Pharmaceuticals up 148.9%.

Get Quote for

Portfolio Strategies Featuring PLX

Did Protalix BioTherapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

PLX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: Israel
  • Headquarters State/Province: N/A
  • Incorporation Country: United States
  • Incorporation State/Province: Florida
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Protalix BioTherapeutics, Inc. is a biopharmaceutical company engaged in the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx® protein expression system.

Recent Quotes

Symbol Price Chg Chg % Market Cap
PLX 4.15 -0.03 -0.72% 388.36M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.